One CTP inhibitor, dalcetrapib, showed a potential benefit in individuals with a specific genetic variant, leading to a subsequent trial focused on that genotype.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.